% Expired Patents = 25.0

EPO Patents = 3

Forward Citations = 1

Loading Chart...

10 inventors (with patents filed for the assignee):

Geoffrey Phillip Symonds (4 out of 15 patents)

Jeffrey S Bartlett (3 out of 6 patents)

Ming Yan (3 out of 12 patents)

4. Chi-Lin Lee (2 out of 4 patents)

5. Jeffrey Ahlers (2 out of 2 patents)

6. Gene-Errol Eugenio Ringpis (2 out of 2 patents)

7. Christopher Walter Alma (1 out of 2 patents)

8. Louis Randall Breton (1 out of 2 patents)

9. Anthony Dominic Kelleher (1 out of 6 patents)

10. Kazuo Suzuki (1 out of 2 patents)

4 patents: Sort by Forward Citations

1. 11795461 - Compositions and methods for treating beta-hemoglobinopathies (2023-10-24),

2. 11213548 - Modulatable switch for selection of donor modified cells (2022-01-04),

3. 11008630 - Methods for discriminating between HIV-1 and lentiviral vectors (2021-05-18),

4. 10961537 - Compositions and methods for treating beta-hemoglobinopathies (2021-03-30),

Company Overview

CSL Gene Therapy is a leading biotechnology company that specializes in developing and commercializing gene therapy treatments for rare and genetic disorders. With a focus on innovative research and cutting-edge technology, CSL Gene Therapy is dedicated to improving the lives of patients worldwide. Learn more about our groundbreaking work at our website.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#10 in Parkville

#1,030 in Australia

Parkville, Australia

Csl Gene Therapy Pty Ltd.

Forward Citations = 1

10 inventors:

Geoffrey Phillip Symonds (4 out of 15 patents)

Jeffrey S Bartlett (3 out of 6 patents)

Ming Yan (3 out of 12 patents)

4. Chi-Lin Lee (2 out of 4 patents)

5. Jeffrey Ahlers (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Csl Gene Therapy Pty Ltd.. Retrieved from https://idiyas.com/company/csl-gene-therapy-pty

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]